RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Bristol-Myers earnings jump 27 percent, but stock falls

    Higher sales of key new medicines and cost cuts helped lift drugmaker Bristol-Myers Squibb Co.'s first-quarter profit by nearly 27 percent. The maker of melanoma drug Yervoy and schizophrenia and bipolar disorder treatment Abilify trounced Wall Street'...
  • Pfizer, despite dollar and generics fight, still impresses

    Cost-cutting and sales of new drugs helped Pfizer overcome a strong dollar and patent expirations to beat Wall Street projections for the first quarter, though it cut its outlook for the year, citing the unfavorable currency exchange rates. The world's...
  • Merck hurdles Wall Street forecasts

    Drugmaker Merck & Co. easily beat Wall Street expectations, sending its shares up sharply, despite first-quarter profit plunging 44 percent. Income was hurt by the sale of its consumer health business, unfavorable currency exchange rates and competition...
  • Hospira earnings rise 11 percent with Pfizer deal pending

    Hospira earnings rise 11 percent with Pfizer deal pending
    Injectable drugs company Hospira reported first-quarter 2015 results Tuesday that beat expectations. Pharmaceutical giant Pfizer offered to buy the Lake Forest company in February for about $15.23 billion. Here's a snapshot of the quarter, and a bit...
  • FDA deal sharply limits Medtronic infusion pump manufacturing, sales

    MINNEAPOLIS Medtronic has entered an agreement with the Food and Drug Administration to stop selling an infusion pump except in rare cases because the company failed to fix manufacturing problems that may cause the implantable devices to deliver too...
  • Mylan rejects Teva Pharmaceutical's takeover bid

    PITTSBURGH Mylan on Monday rejected Teva Pharmaceutical Industries' unsolicited takeover proposal, saying it "grossly undervalues" Mylan, would give Mylan shareholders "low-quality, high-risk" Teva stock, and expose Mylan shareholders "to a problematic...
  • Why the execution drug shortage won't go away in Florida or elsewhere

    Why the execution drug shortage won't go away in Florida or elsewhere
    In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio,...
  • Johnson& Johnson beats Street 1Q forecasts

    Johnson & Johnson's first-quarter profit uncharacteristically fell 8.6 percent, hurt by sharply unfavorable exchange rates, a major divestiture and competition to its new hepatitis C drug. The results from the world's biggest maker of health care...
  • IMS: US prescription drug spending jumped 13 pct. in 2014

    U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Spending rose 13 percent, the biggest...
  • Taxpayers' Costs For Unregulated Drug Prescriptions Explode By 3,000% In Three Years

    Taxpayers' Costs For Unregulated Drug Prescriptions Explode By 3,000% In Three Years
    Unregulated drugs produced by controversial compounding pharmacies are costing Connecticut taxpayers up to $24 million this year in prescription payments on behalf of state employees and retirees, a stunning 3,000 percent increase from their $800,000...
  • Mylan makes official bid for Perrigo in generic drug contest

    Generic drugmaker Mylan is making official its offer for over-the-counter medicines maker Perrigo as it remains at the center of a three-way battle: Mylan wants to buy Perrigo, while a larger rival wants to buy Mylan. Perrigo has already rejected Mylan's...